Summit Therapeutics Inc. (SMMT) — DEFA14A Filings
All DEFA14A filings from Summit Therapeutics Inc.. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (1)
-
Summit Therapeutics Files Proxy Statement Materials
— Jun 13, 2024 Risk: low
Summit Therapeutics Inc. filed a Definitive Additional Materials (DEFA14A) on June 13, 2024. This filing pertains to information required in a proxy statement,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX